Royal Bank of Canada has lowered its price objective on Gen Digital (NASDAQ:GEN) from $26.00 to $24.00, maintaining a "sector perform" rating on the cybersecurity firm, according to a research note cited by Benzinga. The revision, issued Monday, now implies a modest upside of roughly 1.30% from where shares were trading, a far more conservative stance than the one the firm held just weeks earlier.
The downgraded target lands amid a broader reassessment of Gen Digital's valuation by Wall Street. Wall Street Zen moved the stock from "buy" to "hold" in mid-August, while Weiss Ratings further trimmed its already lukewarm assessment in early October. Not every analyst has turned cautious, however: Barclays raised its target to $32.00 and Wells Fargo lifted its own to $28.00, both in early August, suggesting a split in how analysts read the company's near-term prospects. For everyday users of Gen Digital's consumer products - Norton, Avast, LifeLock, Avira, AVG and others - the financial maneuvering is a reminder that the security tools protecting their devices sit inside a competitive, consolidating industry where trust and transparency matter; consumers evaluating their own digital protections are increasingly drawn to a VPN with a clear privacy policy rather than bundled suites with opaque data practices.
A Mixed Signal From Analysts
Taken together, the current analyst landscape paints a company viewed as fairly valued rather than undervalued or overextended. Of the eight analysts tracked by MarketBeat, one rates the stock Strong Buy, one rates it Buy, and six rate it Hold, producing a consensus "Hold" rating and an average price target of $30.25 - notably higher than Royal Bank of Canada's revised figure. That gap between the most conservative and most bullish targets underscores genuine disagreement about how much credit Gen Digital deserves for its recent earnings performance versus how much risk is baked into its balance sheet.
Earnings Beat, But Balance Sheet Raises Questions
Gen Digital's most recent quarterly results, released August 6th, exceeded expectations on both the top and bottom lines. The company reported $0.71 in earnings per share against a consensus estimate of $0.69, with revenue of $1.34 billion topping the $1.31 billion analysts had forecast. Year-over-year revenue growth came in at 6.3%, and return on equity stood at an unusually high 55.93%. Management's guidance for fiscal 2027 - EPS between $2.870 and $2.970 - signals confidence in continued growth. Yet the company's debt-to-equity ratio of 3.00, paired with a current ratio of just 0.47, points to a highly leveraged balance sheet with limited short-term liquidity cushion, a factor likely weighing on some analysts' caution despite solid operating performance.
Insider Sales and Institutional Positioning
Recent insider activity adds another layer to the picture. Chief Operating Officer Bryan Seuk Ko sold over 28,000 shares in early September under a pre-arranged trading plan, while insider Travis Witteveen sold 30,000 shares in August. Collectively, insiders offloaded more than 558,000 shares last quarter, though such sales - particularly those executed under Rule 10b5-1 plans - are routine and do not necessarily reflect a negative outlook. Institutional investors, meanwhile, continue to hold the overwhelming majority of the company's stock, at 81.38%, with several funds significantly increasing their positions in recent quarters, including Artemis Investment Management, which grew its stake by more than 285%.
